Elena Palmisani

Elena Palmisani

Auto-generated profile, based on publicly available information

Elena Palmisani

Hematology Unit IRCCS Istituto Giannina Gaslini Genova Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2021 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
Maurizio MianoMaurizio Miano
Maurizio Miano
AGAlice Grossi
Alice Grossi
GDGianluca Dell'ORso
Gianluca Dell'ORso
MLMarina Lanciotti
Marina Lanciotti
FFFrancesca Fioredda
Francesca Fioredda
CDCarlo Dufour
Carlo Dufour

24 August 2021 in Genes
Verified
Journal Article
Open access
PDF file
AGAlice Grossi
Alice Grossi
Maurizio MianoMaurizio Miano
Maurizio Miano
MLMarina Lanciotti
Marina Lanciotti
FFFrancesca Fioredda
Francesca Fioredda
DGDaniela Guardo
Daniela Guardo
Isabella CeccheriniIsabella Ceccherini
Isabella Ceccherini
Inborn errors of immunity (IEI) include a large group of inherited diseases sharing either poor, dysregulated, or absent and/or acquired function in one or more components of the immune system. Next-generation sequencing (NGS) has driven a rapid increase in the recognition of such defects, though the wide heterogeneity of genetically diverse but phenotypically overlapping diseases has often prevented the molecular characterization of the most complex patients. Two hundred and seventy-two patients were submitted to three successive NGS-based gene panels composed of 58, 146, and 312 genes. Along with pathogenic and likely pathogenic causative gene variants, accounting for the corresponding disorders (37/272 patients, 13.6%), a number of either rare (probably) damaging variants in genes unrelated to patients’ phenotype, variants of unknown significance (VUS) in genes consistent with their clinics, or apparently inconsistent benign, likely benign, or VUS variants were also detected. Finally, a remarkable amount of yet unreported variants of unknown significance were also found, often recurring in our dataset. The NGS approach demonstrated an expected IEI diagnostic rate. However, defining the appropriate list of genes for these panels may not be straightforward, and the application of unbiased approaches should be taken into consideration, especially when patients show atypical clinical pictures.

22 February 2023 in HemaSphere
Verified
Journal Article
Open access
EPElena Palmisani
Elena Palmisani
MMMaurizio Miano
Maurizio Miano
AGAlice Grossi
Alice Grossi
MLMarina Lanciotti
Marina Lanciotti
MLMichela Lupia
Michela Lupia
FFFrancesca Fioredda
Francesca Fioredda
Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disorder of lymphocyte homeostasis classically due to mutation of FAS, FASL, and CASP10 genes (ALPS-FAS/CASP10). Despite recent progress, about one-third of ALPS patients does not carry classical mutations and still remains gene orphan (ALPS-U, undetermined genetic defects). The aims of the present study were to compare the clinical and immunological features of ALPS-FAS/CASP10 versus those of ALPS-U affected subjects and to deepen the genetic characteristics of this latter group. Demographical, anamnestic, biochemical data were retrieved from medical record of 46 ALPS subjects. An enlarged panel of genes (next-generation sequencing) was applied to the ALPS-U group. ALPS-U subjects showed a more complex phenotype if compared to ALPS-FAS/CASP10 group, characterized by multiorgan involvement (P = 0.001) and positivity of autoimmune markers (P = 0.02). Multilineage cytopenia was present in both groups without differences with the exception of lymphocytopenia and autoimmune neutropenia that were more frequent in ALPS-U than in the ALPS-FAS/CASP10 group (P = 0.01 and P = 0.04). First- and second-line treatments were able to control the symptoms in 100% of the ALPS-FAS/CASP10 patients, while 63% of ALPS-U needed >2 lines of treatment and remission in some cases was obtained only after target therapy. In the ALPS-U group, we found in 14 of 28 (50%) patients 19 variants; of these, 4 of 19 (21%) were known as pathogenic and 8 of 19 (42%) as likely pathogenic. A characteristic flow cytometry panel including CD3CD4-CD8-+TCRαβ+, CD3+CD25+/CD3HLADR+, TCR αβ+ B220+, and CD19+CD27+ identified the ALPS-FAS/CASP10 group. ALPS-U seems to represent a distinct entity from ALPS-FAS/CASP10; this is relevant for management and tailored treatments whenever available.

12 November 2019 in Blood Advances
Verified
Journal Article
Open access
PDF file
FFFrancesca Fioredda
Francesca Fioredda
ECEnrico Cappelli
Enrico Cappelli
AMAnthea Mariani
Anthea Mariani
ABA. Beccaria
A. Beccaria
EPE. Palmisani
E. Palmisani
Maurizio MianoMaurizio Miano
Maurizio Miano
Key Points: Immunological dysregulation may underlie unusual autoimmune diseases, which also deserve to be investigated from a genetic point of view.

Verified
Journal Article
Open access
PDF file
BCBenedetta Chianucci
Benedetta Chianucci
AGAlice Grossi
Alice Grossi
GDGianluca Dell'Orso
Gianluca Dell'Orso
EPElena Palmisani
Elena Palmisani
MLMarina Lanciotti
Marina Lanciotti
Maurizio MianoMaurizio Miano
Maurizio Miano
In recent years, the knowledge about the immune-mediated impairment of bone marrow precursors in immune-dysregulation and autoimmune disorders has increased. In addition, immune-dysregulation, secondary to marrow failure, has been reported as being, in some cases, the most evident and early sign of the disease and making the diagnosis of both groups of disorders challenging. Dyskeratosis congenita is a disorder characterized by premature telomere erosion, typically showing marrow failure, nail dystrophy and leukoplakia, although incomplete genetic penetrance and phenotypes with immune-dysregulation features have been described. We report on a previously healthy 17-year-old girl, with a cousin successfully treated for acute lymphoblastic leukemia, who presented with leukopenia and neutropenia. The diagnostic work-up showed positive anti-neutrophil antibodies, leading to the diagnosis of autoimmune neutropenia, a slightly low NK count and high TCR-αβ+-double-negative T-cells. A next-generation sequencing (NGS) analysis showed the 734C>A variant on exon 6 of the TINF2 gene, leading to the p.Ser245Tyr. The telomere length was short on the lymphocytes and granulocytes, suggesting the diagnosis of an atypical telomeropathy showing with immune-dysregulation. This case underlines the importance of an accurate diagnostic work-up of patients with immune-dysregulation, who should undergo NGS or whole exome sequencing to identify specific disorders that deserve targeted follow-up and treatment.

22 June 2017 in Journal of Chemotherapy
Verified
Journal Article
Closed access
AMAlessio Mesini
Alessio Mesini
GCGiuliana Cangemi
Giuliana Cangemi
EPElena Palmisani
Elena Palmisani
CDCarlo Dufour
Carlo Dufour
ECElio Castagnola
Elio Castagnola
(2018). Hepatic veno-occlusive disease during isavuconazole administration. Journal of Chemotherapy: Vol. 30, No. 1, pp. 63-64.